Middle East and Africa Botulinum Toxin Market Size and Forecasts, Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product, Application, and End User

The Middle East and Africa botulinum toxin market size is expected to reach US$ 453.55 million by 2030 from US$ 172.57 million in 2022. The market is estimated to grow at a CAGR of 12.8% from 2022 to 2030.

The global botulinum toxin market, by application, is segmented into medical and aesthetics. The medical segment held the largest share of the market in 2022 and is expected to retain its dominance during the forecast period.

Botulinum toxin is a drug used to treat and manage a variety of therapeutic and aesthetic conditions. Chronic migraine, spastic disorders, cervical dystonia, and detrusor hyperactivity are all examples of medicinal usage.t is in the neurotoxin class of medications. This activity reviews the indications, action, and contraindications for botulinum toxin therapy as a valuable agent for therapeutic and cosmetic treatment in the clinical setting. The medical segment in the botulinum toxin market is sub-segmented as chronic migraine (CM), muscle spasm, overreactive bladder, hyperhidrosis, and others. In 2010, the Food and Drug Administration (FDA) of the United States approved onabotulinumtoxinA (Botox) as a prophylactic treatment for CM. OnabotulinumtoxinA is beneficial in reducing the frequency and severity of headaches in people with CM. Furthermore, the Aesthetic segment is sub-segmented into crow’s feet, forehead lines, frown lines/ glabellar, square jaw/ masseter, and others.

By product, the Middle East and Africa botulinum toxin market is segmented into Botox, Dysport Xeomin, and others. The botulinum toxin market, by end-user, the market is fragmented into hospitals and clinics, specialty and dermatology clinics, and others. The specialty and dermatology clinics segment held the largest share of the market in 2022 and is anticipated to register the highest CAGR in the market during the forecast period.

Based on country, the Middle East and Africa botulinum toxin market is divided into Saudi Arabia, UAE, South Africa, Lebanon, Oman, Jordan, Qatar, Kuwait, Bahrain, and the Rest of the Middle East and Africa. Lebanon is well known for its cosmetic surgeries, and the number of aesthetic procedures is expanding in Lebanon, where treatments like dermal fillers (DFs) hold a major share in the anti-aging industry. Furthermore, the rapid global development of the pharmacy profession has also led pharmacists to enter the cosmetic industry by administering injectable DFs to those in need. According to TRT World, in 2020, Lebanon was recognized long time ago as the Botox capital of the Middle East region. The increasing demand for less aggressive or invasive aesthetic procedures, particularly those with short duration and quick recovery, has created opportunities for pharmacists to practice their clinical expertise in this regard. This small Middle Eastern country has one of the highest pharmacists-to-population ratios in the world. However, the pharmacy profession is still constantly evolving and entering into many fields. Therefore, various legislative procedures, training, licensing, and developed pharmacy curricula are very necessary prior to the practice of DFs by pharmacists in Lebanon.

Botulinum toxin treatments are the most common and most popular wrinkle treatments in Lebanon. Botulinum toxin injections of the lower face and neck are useful, simple, and safe procedures that should be part of every aesthetic practitioner's arsenal. Various clinics in Lebanon provide Botox treatments, some of them are namely Dr Andre Chraim - Plastic Surgery and Elie Melhem Clinc. The Elie Melhem Clinic, located in Mansouriyeh, Beirut, Lebanon, offers patients Botox Injections procedures among its total of 24 available procedures across 9 different specialties. A Botox Injection procedure costs from US$ 400 to US$ 496, whilst the national average price is approximately US$ 350. Many specialists are available at the Clinic, and they are accredited by International Organization for Standardization (ISO) Certification.

Therefore, the aforementioned factors are expected to boost the market growth in the country.

The botulinum toxin market majorly consists of the players such as AbbVie Inc., Merz Pharma, Medytox, Sanofi, Ipsen Pharma, Galderma, Revance Therapeutics Inc., Lanzhou Institute of Biological Products Co., Ltd., Candela Medical, and Daewoong Pharmaceutical Co. Ltd. amongst others.

The World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC), Health Education England (HEE), Dubai Health Authority, Government of Dubai Media Office (GDMO), National Institute for Health and Care Excellence (NICE), and Therapeutic Goods Administration (TGA) are a few key primary and secondary sources referred to while preparing the report on the neurotoxin market.